XML 15 R5.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Cash Flows - USD ($)
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash flows from operating activities:    
Net loss $ (1,436,069) $ (4,542,078)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation and amortization expense 3,103,306 3,406,166
Reduction in the carrying amount of right-of-use assets 855,553 855,553
Share-based compensation 236,160 227,083
Increase (decrease) in non-cash contingent consideration 93,229 (936,072)
Increase in cash surrender value of life insurance policies over premiums paid (131,967) (180,081)
Noncash interest expense 16,085 19,377
Loss on disposal of assets 0 2,691
Life insurance proceeds 0 (237,089)
Accounts receivable 1,270,864 (1,552,449)
Inventories, net 2,448,605 1,072,295
Other current assets and other assets 818,959 1,022,718
Operating lease liabilities (662,117) (645,009)
Accounts payable and other current liabilities (1,334,701) (667,065)
Other long-term liabilities (348,409) (362,844)
Net cash provided by (used in) operating activities 4,929,498 (2,516,804)
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract]    
Additions to property and equipment 97,904 64,178
Life insurance policy proceeds received 0 237,556
Increase in cash surrender value of life insurance policies (47,000) 0
Net investment in manufacturing 1,447,695 0
Additions to intangible assets 40,560 88,727
Net cash (used in) provided by investing activities (1,633,159) 84,651
Cash flows from financing activities:    
Proceeds from ATM offering, net 5,266,334 0
Borrowings on line of credit 0 32,988,920
Payments on line of credit (10,035,437) (29,681,472)
Cash settlement of contingent consideration (1,031,197) (1,251,499)
Payments made in connection with repurchase of common shares (263,478) (480,666)
Net cash (used in) provided by financing activities (6,063,778) 1,575,283
Net decrease in cash and cash equivalents (2,767,439) (856,870)
Cash and cash equivalents at beginning of period 17,964,184 18,321,624
Cash and cash equivalents at end of period $ 15,196,745 $ 17,464,754